Keywords: sanofi, zentiva, buy, cleared, conditions, ppf, takes
Sanofi's Zentiva buy cleared, on conditions; PPF takes action to prevent deal
Article | 09 February 2009
French drug major Sanofi-Aventis has received European Commission approval for its 1.8 billion-euro ($2.3 billion) acquisition of Czech generic firm Zentiva. In ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
